Crowdonomics
EndoSure, Inc.

Reg CF · Common Stock · Dec 2024

ClosedReg CFCommon Equity
via StartEngineView campaign
Raised
$0 / $1.2M max
0% of ceiling
Investors
—
—
Post-money valuation
$15M
pre-money + amount raised

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$15K
−$172K
FY2022
$225K
−$208K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$14,850
$224,716
Cost of goods sold
$5,400
$22,999
Gross margin
64%
90%
Net income
-$171,953
-$208,368
Taxes paid
$0
$0
Balance sheet
Cash
$23,277
$2,652
Accounts receivable
$0
$1,376
Total assets
$23,277
$42,473
Short-term debt
$23,166
$167,774
Long-term debt
$194,830
$422,394
Total liabilities
$217,996
$590,168
Other
Headcount
—
8

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$15M
Post-money$15M
Price / share$3.75

Perks

Invest $1,000+ within the first 2 weeks | 10% bonus shares · until Dec 19, 202410% bonus$1K+

Offering details

Target$123,998
Max$1,234,999
Min investment$499
OpenedDec 6, 2024
DeadlineMar 3, 2025
ClosedMar 3, 2025
Days active87

Links & provenance

Source: Manual
0001665160-24-001732

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.